[Passive protective effect of peptically metabolized and chemically stabilized immunoglobulins in septic infections].
D000818:Animals; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008589:Meningococcal Infections / Q000188:drug therapy; D051379:Mice; D010587:Phagocytosis; D011008:Pneumococcal Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013997:Time Factors
D007136:Immunoglobulins
Uber die passive Schutzwirkung von peptisch abgebauten und chemisch stabilisierten Immunglobulinen bei septisch verlaufenden Infektionen